Skip to main content
. 2021 May 13;15:2013–2024. doi: 10.2147/DDDT.S289473

Figure 7.

Figure 7

Schematic map of EGCG in AD. EGCG treatment reduced Tau hyperphosphorylation, BACE1 expression, and Aβ1-42 expression to improve the antioxidant system and reduce AchE activity, which improved the learning and memory function of AD rats.